West Pharmaceutical Services Inc (NYSE:WST)
| 347.16 BATS BZX Real-Time Price As of 3:38pm ET |  +6.29 / +1.85%Today’s Change | 206.19 Today|||52-Week Range 424.00 | +47.51% Year-to-Date |
Latest WST News | Press Releases
| BDX or WST: Which Is the Better Value Stock Right Now? Mar 29 / Zacks.com - Paid Partner Content | Reasons to Retain West Pharmaceutical (WST) in Your Portfolio Mar 23 / Zacks.com - Paid Partner Content |
| Merit Medical (MMSI) Down 0.7% Since Last Earnings Report: Can It Rebound? Mar 24 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 340.87 |
| Today’s open | 342.42 |
| Day’s range | 342.42 - 348.68 |
| Volume | 248,594 |
| Average volume (3 months) | 619,128 |
| Market cap | $24.8B |
Data as of 3:38pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | -11.47% |
| Earnings growth (this year) | -14.02% |
| Earnings growth (next 5 years) | +3.80% |
| Revenue growth (last year) | +1.94% |
| P/E ratio | 45.0 |
| Price/Sales | 6.18 |
| Price/Book | 9.23 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZBHZimmer Biomet Holdin... | +2.48 | +1.96% |
| SAUHFStraumann Holding AG | +9.75 | +6.99% |
| PODDInsulet Corp | +3.66 | +1.16% |
| BAXBaxter International... | +0.13 | +0.32% |
Data as of 3:38pm ET, 03/31/2023
Financials
| Next reporting date | April 27, 2023 |
| EPS forecast (this quarter) | $1.65 |
| Annual revenue (last year) | $2.9B |
| Annual profit (last year) | $585.9M |
| Net profit margin | 20.30% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Exton, Pennsylvania |
Forecasts
